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A rich residential micro¯ora is harboured by the dis-
tal outer root sheath of the hair follicle and the hair
canal ± normally without causing skin diseases.
Although the basic mechanisms involved in the
development of in¯ammation during acne vulgaris
remain unclear, microbial agents might play an
important role in this process. In this study we have
analyzed by in situ hybridization and immunohisto-
chemistry the expression patterns of two antimicro-
bial peptides, human b defensin-1 and human b
defensin-2, in healthy human hair follicles as well as
in perilesional and intralesional skin of acne vulgaris
lesions such as comedones, papules, and pustules.
Strong defensin-1 and defensin-2 immunoreactivity
was found in all suprabasal layers of the epidermis,
the distal outer root sheath of the hair follicle, and
the pilosebaceous duct. Marked defensin-1 and
defensin-2 immunoreactivity was also found in the
sebaceous gland and in the basal layer of the central
outer root sheath including the bulge region. The
majority of acne biopsies displayed a marked upre-
gulation of defensin-2 immunoreactivity in the
lesional and perilesional epithelium ± in particular in
pustules ± and a less marked upregulation of defen-
sin-1 immunoreactivity. The upregulation of b-
defensin expression in acne vulgaris lesions compared
to controls suggests that b-defensins may be involved
in the pathogenesis of acne vulgaris. J Invest Dermatol
117:1120±1125, 2001
T
he hair canal, distal outer root sheath (ORS) of the
hair follicle, and the pilosebaceous duct constitute
major ports of entry for microbial invasion in humans
and harbour a rich residential micro¯ora such as
Propionibacterium acnes, Staphylococcus epidermidis,
Demodex folliculorum, and Malassezia furfur, which, however, do
not normally cause disease (Paus, 1997; Paus et al, 1999). The distal
ORS and the pilosebaceous duct are also characterized by many
features of immunologic activity such as classical and nonclassical
major histocompatibility complex class I expression, intercellular
adhesion molecule-1 expression, and the presence of intraepithelial
Langerhans cells and perifollicular macrophages (Paus, 1997; Paus et
al, 1999; Christoph et al, 2000). This area of the pilosebaceous unit
is also a hot spot in the development of acne vulgaris lesions.
Hypercorni®cation of the distal ORS and the pilosebaceous duct
in concert with increased sebum production and abnormalities of
the microbial ¯ora are considered to be major factors in the
pathogenesis of acne vulgaris (cf. Cunliffe and Simpson, 1998). The
role of microbial agents is still not clear, however. P. acnes is likely
to be the major organism as selective antibiotic studies reveal that
only antibiotics that suppress P. acnes in vivo are associated with
clinical bene®t. Furthermore there is some relationship between P.
acnes resistance and clinical failure (Eady et al, 1989; 1993; Bojar et
al, 1994). Although many acne vulgaris patients respond well to
antibiotic drugs, there is little relationship between the numbers of
bacteria on the skin surface and the severity of acne (Leyden et al,
1975; Cove et al, 1983). Colonization of the pilosebaceous duct is a
feature of established comedones and early in¯ammatory lesions
(Leeming et al, 1985; 1988). Why some colonized ducts become
in¯amed and others do not is uncertain. Variation in the
microenvironment of the duct could be important. Such micro-
environmental variations are likely to in¯uence the production and
activity of in¯ammatory mediators (Holland et al, 1978; 1998). P.
acnes produces many likely candidates for in¯ammation such as
lipases, neuramidases, phosphatases, and proteases (Greenman et al,
1983). One alternative hypothesis might be that acne vulgaris
patients suffer from a dysregulation of the production of innate and
speci®c antimicrobial peptides.
More than 500 antimicrobial peptides have been described in
plants, insects, amphibians, and mammals, with broad-spectrum
activity against bacteria, fungi, and viruses, representing an integral
part of innate immunity (Ganz, 1999; Boman, 2000). Mammalian
defensins are a family of cationic antimicrobial peptides 28±42
amino acids long containing three disul®de bonds. They have been
divided into two subtypes, the a-defensins and the b-defensins
(Diamond and Bevins, 1998). The a-defensins are found in
neutrophil granules or in the paneth cells of the small intestine
(Ganz and Lehrer, 1998). The two b-defensins so far identi®ed,
human b defensin-1 (hBD1) and human b defensin-2 (hBD2), are
produced in various epithelia (Harder et al, 1997; Valore et al,
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1998). hBD1 was ®rst isolated from human blood ®ltrates and
hBD2 was ®rst isolated from human psoriatic scale (Bensch et al,
1995; Harder et al, 1997). Recent studies have shown hBD1 and
hBD2 expression in the skin by the polymerase chain reaction and
in situ hybridization (Fulton et al, 1997; Harder et al, 1997).
In view of the proposed role for ductal P. acnes in acne vulgaris
(Holland et al, 1978; 1998) we have studied the expression patterns
of hBD1 and hBD2 in human terminal hair follicles and in acne
vulgaris lesions compared to healthy pilosebacous follicles.
MATERIALS AND METHODS
Tissue specimens Scalp skin containing terminal hair follicles was
collected from 10 individuals undergoing cosmetic surgery (facelifts).
Biopsies were ®xed in 10% formalin for 8 h prior to embedding in
paraf®n wax. Biopsies of normal pilosebaceous follicles were taken from
the backs of ®ve healthy volunteers and compared to lesional skin
biopsies taken from the backs of 11 acne vulgaris patients. Biopsies were
taken of blackheads (n = 4), whiteheads (n = 1), papules (n = 2), and
pustules (n = 4). All biopsies were ®xed in 4% paraformaldehyde for
2.25 h and embedded in Paraplast embedding medium (Paraplast X-tra,
Sigma). Ethical approval was obtained from all patients and all patients
had been off acne therapy for 4 wk. No patient had previously received
oral isotretinoin.
In situ hybridization Riboprobes for in situ hybridization were
prepared using hBD1 and hBD2 plasmids, which were generated by
reverse transcription polymerase chain reaction (Fulton et al, 1997; Ali et
al, 2001). The plasmids were linearized for in situ hybridization by
digestion with apropriate restriction enzymes and antisense and sense
probes were prepared from the linearized fragments (Ali et al, 2001). In
situ hybridization was performed as follows: 4 mm paraf®n sections were
cut onto superfrost slides (BDH). Sections were deparaf®nized,
rehydrated, and transferred to RNase-free water. Tissue sections were
microwaved in RNase-free preheated 10 mM citrate buffer solution,
pH 6.0, for 10 min, transferred quickly and cooled in RNase-free water,
and washed in RNase-free phosphate-buffered saline (PBS), pH 7.2, for
5 min. The sections were prehybridized for 3 h at 42°C and then
hybridized at 42°C. Sections were subsequently washed in 2 3 sodium
citrate/chloride buffer (SSC) for 10 min. Following stringency washes to
0.1 3 SSC/50% formamide at 42°C, sections were incubated in buffer 1
with 1% normal sheep serum, 0.3% Triton X-100 for 30 min at room
temperature. Antidigoxigenin antibody linked to alkaline phosphatase
(Boehringer) was applied at 1:500 dilution in buffer 1 (100 mM Tris-
HCl, 150 mM NaCl) with normal sheep serum, 0.3% Triton X-100 for
90 min at room temperature. After rinsing in buffer 1 twice for 5 min
and buffer 2 (50 mM Tris-HCl, 100 mM NaCl, 50 mM MgCl2) for
5 min sections were treated with 5-bromo-4-chloro-3-indolyphosphate/
Nitro blue tetrazolium (BCIP/NBT) liquid substrate system (Sigma)
overnight at room temperature. The reaction was stopped in buffer 3
(10 mM Tris-HCl, 1 mM ethylenediamine tetraacetic acid). Slides were
then air dried and mounted in Aquamount (BDH).
Immunohistochemistry Localization of hBD1 and hBD2
immunoreactivity (IR) was carried out using two sets of speci®c rabbit-
anti-human polyclonal antibodies. The ®rst set of anti-hBD1 and anti-
hBD2 antibodies were a kind gift from Dr. T. Ganz, Los Angeles, CA
(Liu et al, 1998; Valore et al, 1998). The second set of anti-hBD1 and
anti-hBD2 antibodies was generated in our laboratory. The speci®city of
these antibodies was determined by dot blot analysis (Ali et al, 2001).
Five micron sections were cut on a rotary microtome (Biocut, Reichert-
Jung) and placed on electrostatically charged slides (Superfrost Plus,
BDH). All sections were baked for a minimum of 30 min at 60°C.
Sections were de-waxed in xylene and rehydrated. IR was detected
using a standard avidin±biotin complex peroxidase method (Vectastain
Universal Elite ABC kit, Vector Laboratories). Endogenous peroxidase
activity was blocked with 3% hydrogen peroxide in ice-cold methanol
(±20°C) for 10 min and rinsed in PBS. Non-speci®c binding was
blocked with a 1:5 dilution of normal horse serum in PBS for 10 min.
Sections were incubated with a 1:1500 dilution of either anti-hBD1 or
anti-hBD2 antibody overnight at 4°C. Slides were washed twice in Tris-
buffered saline (pH 7.6). The secondary biotinylated antibody (Vectastain
Universal Elite ABC kit, Vector Laboratories) was applied at room
temperature for 45 min. Sections were again washed twice in Tris-
buffered saline before application of the streptavidin horseradish
peroxidase tertiary antibody, 30 min at room temperature. The reaction
product was visualized using diaminobenzidine (Liquid DAB substrate
pack, BioGenex) and sections were counterstained with Mayer's
hematoxylin.
RESULTS
In this study we have investigated the patterns of hBD1 and hBD2
mRNA and protein expression in terminal scalp hair follicles as well
as in normal pilosebaceous follicles and acne vulgaris lesions from the
back.
HBD1 and hBD2 mRNA is expressed in terminal scalp hair
follicles We have analyzed sense and antisense staining of hBD1
(Fig 1A±H) and hBD2 (Fig 1I±P), respectively. hBD1 (Fig 1A±
D) and hBD2 (Fig 1I±L) sense controls only displayed nonspeci®c
staining con®ned to the stratum corneum (Fig 1I) and in the distal,
highly differentiated inner root sheath (IRS) (Fig 1B, C). Strong
homogeneous staining for hBD1 mRNA expression was detected
in the basal and suprabasal layers of the epidermis (Fig 1E) as well
as in the distal outer root sheath (ORS) (Fig 1F). In contrast, the
proximal ORS showed strong hBD1 mRNA expression only in
the upper suprabasal layers (Fig 1G). Strong hBD1 mRNA
expression was also found in the less differentiated, proximal IRS
(Fig 1G) as well as in the sebaceous gland and pilosebaceous duct
(Fig 1F, H). Similarly, homogeneous hBD2 mRNA expression
was observed in all layers of the epidermis (Fig 1M) and the distal
ORS (Fig 1N). In addition, hBD2 mRNA expression was also
observed in the suprabasal layers of the proximal ORS (Fig 1O)
and in the sebaceous gland and duct (Fig 1N, P). No hBD1 or
hBD2 mRNA was detected in the hair matrix or the dermal papilla
(DP) (not shown).
HBD1 and hBD2 IR in terminal scalp hair follicles and
pilosebaceous follicles In contrast to the mRNA expression
patterns, strong hBD1 (Fig 2A, C) and hBD2 (Fig 2B, G) IR was
only seen in the suprabasal layers of the epidermis, the distal ORS,
sebaceous gland, and sebaceous duct. Unlike the epidermis and the
distal part of the hair follicle, marked hBD1 (Fig 2A) and hBD2
(Fig 2B) IR was found on basal layer keratinocytes in the isthmus
and bulge area of the ORS. Weaker hBD1 (Fig 2A, C) and hBD2
(Fig 2B, G) IR was also present in the central and proximal regions
of the ORS as well as in the proximal portion of the IRS, whereas
no hBD1 or hBD2 IR was detected in the hair matrix or the DP.
We found consistent expression patterns in all biopsies but some
variations in the levels of hBD1 and hBD2 mRNA and protein
expression between the 10 different sex- and age-matched patients
(hBD1: very strong IR, two; moderate, six; weak, two patients;
hBD2: very strong IR, two; moderate, seven; weak, one patient).
HBD1 and hBD2 IR in acne lesions (back skin) In both
comedones (Fig 2D) and papules (Fig 2E) strong hBD1 IR was
localized in the suprabasal layers of both lesional and perilesional
epithelium, the pilosebaceous duct, the sebaceous gland, and the
Figure 1. hBD1 and hBD2 in situ hybridization. hBD1 sense control (A±D) and hBD2 sense control (I±L) were compared to the corresponding
hBD1 antisense staining (E±H) and hBD2 antisense hybridization (M±P). Selected skin compartments were compared: epidermis (A, E, I, M), the
distal IRS and ORS including the bulge region (B, F, J, N), the proximal IRS and ORS (C, G, K, O), and the sebaceous gland and duct (D, H, L, P).
Purple, nonspeci®c staining is found in the sense controls in the stratum corneum (I) and in the IRS (B, C). Homogeneous, strongly brown, speci®c
antisense staining for both defensins is homogeneously present in all layers of the epidermis (E, M) and the distal ORS including the bulge area (F, N).
Slight hBD2 antisense hybridization is found on the arrector pili muscle (APM). Strong hBD1 and hBD2 antisense hybridization is only detected in the
upper suprabasal layers of the proximal ORS (G, O) and in the sebaceous gland and duct (H, P). (Q, R) Negative controls for hBD1 and hBD2 IR.
Negative controls that were incubated without the primary antibody show no IR in any key compartment of the hair follicle (H, P).
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follicular IRS. Pustules show hBD1 IR in the suprabasal lesional
and perilesional epithelium and the pilosebaceous duct (Fig 2F)
whereas little hBD1 IR was seen in the in¯ammatory area of the
pustule. Compared to healthy controls and the interlesional
epithelium of the same patient, six of 11 acne vulgaris patients
showed an upregulation of hBD1 IR in comedones or papules.
Strong hBD2 IR is seen in the comedonal plug, the suprabasal
layers of the epidermis and lesional epithelium, the IRS,
pilosebaceous duct, and gland in all comedones (Fig 2H) and
papules (Fig 2I). Compared to healthy follicles and other lesions,
the strongest hBD2 upregulation has been found in and around
pustules (in contrast to the interlesional epithelium of the same
patient) including the area of maximal in¯ammation, the suprabasal
perilesional epidermis and lesional epithelium as well as the
pilosebaceous duct and gland (Fig 2J).
HBD1 and hBD2 IR in lesional versus nonlesional skin The
comparison of defensin IR in lesional and nonlesional epithelium
on the same section from each acne vulgaris patient revealed
substantially stronger hBD1 IR in lesional epithelium (Fig 2K)
compared to nonlesional epithelium (Fig 2L). Furthermore, we
found substantially stronger hBD2 IR in lesional epithelium
(Fig 2M) compared to nonlesional epithelium (Fig 2N).
DISCUSSION
In this study we have investigated the mRNA and protein
expression patterns of hBD1 and hBD2 in healthy human
pilosebaceous units as well as in acne vulgaris lesions. We found
strong constitutive mRNA and protein expression of both b-
defensins in the distal ORS surrounding the hair canal and in the
pilosebaceous duct of the hair follicle. This ®nding is consistent
with the concept that these regions are highly exposed to microbial
invasion as well as to the physiologic skin micro¯ora. In contrast,
hair follicle compartments that are rarely exposed to microbial
invasion such as the proximal ORS and IRS as well as the hair
follicle bulb show only very weak hBD1 and hBD2 expression.
Therefore, the patterns of defensin expression shown here suggest
that hBD1 and hBD2 may play a key role in protecting the
pilosebaceous unit from microbial invasion.
Although hBD1 has been reported to be constitutively expressed
and not upregulated under in¯ammatory conditions in oral mucosa
(Mathews et al, 1999), we found a moderate upregulation of hBD1
IR in most acne vulgaris lesions compared to non-lesional skin of the
same patient and also compared to pilosebaceous follicles from
healthy back skin controls. The functional signi®cance of this is not
clear. It is interesting to note that there was strong upregulation of
hBD1 in the proximal IRS of a small pilosebaceous follicle adjacent
to one comedo (Fig 2D). A moderate to strong upregulation of
hBD2 IR was seen in all types of acne lesion. It is important to note
that these observations are based on a limited sample number from
11 acne vulgaris patients. An increase of hBD2 expression has also
been found, however, in other in¯ammatory conditions such as
psoriasis and mastitis (Schonwetter et al, 1995; Stolzenberg et al,
1997; cf. Schroder and Harder, 1999).
There is increasing evidence that pro-in¯ammatory cytokines
(such as interleukin-1b, tumor necrosis factor-a) and bacterial
lipopolysaccharides can upregulate b-defensins (Diamond et al,
1996; Harder et al, 1997; Stolzenberg et al, 1997). Therefore, the
observed upregulation of b-defensins in acne vulgaris lesions is most
probably a secondary response to the marked perilesional in®ltrate.
In this context it is interesting to note that there are marked
differences between hBD1 and hBD2 expression in the perilesional
follicle in Figs 2(D) and 2(H): increased expression of hBD1 is
restricted to the IRS of the follicle whereas hBD2 is strongly
increased throughout the proximal follicle including the me-
senchymally derived DP. These preliminary ®ndings suggests that
in¯ammatory cytokines may be able to upregulate b-defensin
expression in both the distal and proximal follicle. It is important to
note that this is only based on one bulb of a lesional pilosebaceous
unit, however, and many more would need to be studied. This
would be very dif®cult in lesional biopsies as we only observed one
hair follicle bulb in the 11 acne biopsies studied.
Finally, in the normal facelift and back skin biopsies that have
been investigated in this study we detected substantial variations of
the hBD1 and hBD2 IR intensity between sex- and age-matched
patients, between face and back skin, as well as between different
hair follicle types (terminal hair follicles and pilosebaceous follicles).
In further studies it will be interesting to investigate whether good
responders to antibiotic anti-acne treatment differ in their b-
defensin levels and/or activity from bad responders.
In conclusion, this study provides evidence that human b-
defensins are expressed in human hair follicles and that their
expression is upregulated in acne vulgaris lesions.
We thank Dr. Thomas Ganz for donating the hBD1 and hBD2 antibodies and
Dr. Veronique Bataille for her valuable contributions to the study concept.
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